Industry & Policy News

[Susan G. Komen] Susan G. Komen® announced the fourth metastatic breast cancer-focused research grant supported through the Komen Metastatic Breast Cancer Collaborative Research Initiative.

[Telavant] Telavant announced the initiation of the TAHOE study, a Phase II clinical trial of RVT-3101 for the treatment of moderate to severely active Crohn's diesease, with the first patient dosed.

[TFF Pharmaceuticals, Inc.] Uniphar Durbin Ireland, Ltd. and TFF Pharmaceuticals, Inc. announced the opening of an Expanded Access Program enabling patients access to TFF-VORI in the United States, Australia, United Kingdom, Canada, and select countries in Europe.

[Kenya Medical Research Institute] The Kenya Medical Research Institute (KEMRI) commissioned the first- ever, state-of the-art- Stem Cell and Regenerative Medicine Laboratory in Sub-Sahara African Region at its Central Laboratory Complex and Headquarters in Nairobi.

[National Institutes of Health] Lawrence A. Tabak, D.D.S., Ph.D., acting director for the National Institutes of Health, has named Jeanne M. Marrazzo, M.D., as director of NIH’s National Institute of Allergy and Infectious Diseases.

[Fred Hutchinson Cancer Center] The health of our fat cells may influence the health of other organs and obesity researcher Akhila Rajan, PhD, has received a McKnight Foundation award to map that link.